Scheduled for or recently performed (within 4 weeks) standard-of-care PSMA PET
Optional: Scheduled for SOC biopsy of an established or suspected non-osseous, non-nodal metastases.
Willing and able to undergo PET/MRI as part of this research
You may not be if
Unable or unwilling to provide informed consent
Contraindication(s) to or inability to undergo PET/MRI
Participants for whom PET/MRI will delay timely delivery of treatment
Participants requiring intravenous (IV) conscious sedation for imaging care; those requiring mild, oral anxiolytics for the clinical MRI will be allowed to participate as long as the following criteria are met:
Have their own prescription for the medication
The informed consent process is conducted prior to the self-administration of this medication
Come to the research visit with a driver
Clareo Health | Using FAPI PET/MRI to Evaluate Prostate Cancer
